دورية أكاديمية
Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil.
| العنوان: | Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil. |
|---|---|
| المؤلفون: | Milani V; School of Dentistry, Universidade Federal de Goiás (UFG), Goiânia, Goiás, Brazil., Zara ALSA; School of Dentistry, Universidade Federal de Goiás (UFG), Goiânia, Goiás, Brazil., da Silva EN; Universidade de Brasília (UnB), Brasília, Federal District, Brazil., Cardoso LB; Faculty of Administration, Accounting and Economic Sciences, Universidade Federal de Goiás (UFG), Goiânia, Goiás, Brazil., Curado MP; A. C. Camargo, São Paulo, São Paulo, Brazil., Ribeiro-Rotta RF; School of Dentistry, Universidade Federal de Goiás (UFG), Goiânia, Goiás, Brazil. |
| المصدر: | PloS one [PLoS One] 2021 Feb 17; Vol. 16 (2), pp. e0246475. Date of Electronic Publication: 2021 Feb 17 (Print Publication: 2021). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: San Francisco, CA : Public Library of Science |
| مواضيع طبية MeSH: | Delivery of Health Care/*economics , Health Care Costs/*statistics & numerical data , Mouth Neoplasms/*economics, Brazil ; Cost of Illness ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Oropharyngeal Neoplasms/economics |
| مستخلص: | The efficiency of public policies includes the measurement of the health resources used and their associated costs. There is a lack of studies evaluating the economic impact of oral cancer (OC). This study aims to estimate the healthcare costs of OC in Brazil from 2008 to 2016. This is a partial economic evaluation using the gross costing top-down method, considering the direct healthcare costs related to outpatients, inpatients, intensive care units, and the number of procedures, from the perspective of the public health sector. The data were extracted from the Outpatient and Inpatient Information System of the National Health System, by diagnosis according to the 10th Revision of the International Classification of Diseases, according to sites of interest: C00 to C06, C09 and C10. The values were adjusted for annual accumulated inflation and expressed in 2018 I$ (1 I$ = R$2,044). Expenditure on OC healthcare in Brazil was I$495.6 million, which was composed of 50.8% (I$251.6 million) outpatient and 49.2% (I$244.0 million) inpatient healthcare. About 177,317 admissions and 6,224,236 outpatient procedures were registered. Chemotherapy and radiotherapy comprised the largest number of procedures (88.8%) and costs (94.9%). Most of the costs were spent on people over 50 years old (72.9%) and on males (75.6%). Direct healthcare costs in Brazil for OC are substantial. Outpatient procedures were responsible for the highest total cost; however, inpatient procedures had a higher cost per procedure. Men over 50 years old consumed most of the cost and procedures for OC. The oropharynx and tongue were the sites with the highest expenditure. Further studies are needed to investigate the cost per individual, as well as direct non-medical and indirect costs of OC. Competing Interests: The authors have declared that no competing interests exist. |
| References: | Cad Saude Publica. 2014 May;30(5):983-97. (PMID: 24936815) J Clin Oncol. 2015 Oct 10;33(29):3235-42. (PMID: 26351338) N Engl J Med. 2010 Jul 1;363(1):24-35. (PMID: 20530316) An Bras Dermatol. 2009 Jul;84(3):237-43. (PMID: 19668936) Arch Endocrinol Metab. 2018 Oct;62(5):537-544. (PMID: 30462807) Front Public Health. 2018 Jul 27;6:205. (PMID: 30101142) J Mol Diagn. 2012 Jan;14(1):22-9. (PMID: 22166544) Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):541-50. (PMID: 19190158) Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):68-73. (PMID: 17413405) Cost Eff Resour Alloc. 2003 Feb 26;1(1):1. (PMID: 12773220) Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Dec;61(12):1505-1512. (PMID: 30353287) Oral Oncol. 2016 Oct;61:83-8. (PMID: 27688109) Lancet Oncol. 2016 Apr;17(4):440-451. (PMID: 26936027) Glob Health Action. 2018;11(sup3):1589763. (PMID: 30963822) Health Technol Assess. 2006 Apr;10(14):1-144, iii-iv. (PMID: 16707071) Oral Oncol. 2001 Jul;37(5):401-18. (PMID: 11377229) PLoS One. 2018 Jan 11;13(1):e0191132. (PMID: 29324861) Int J Cancer. 2018 Jul 1;143(1):32-44. (PMID: 29405297) Clinics (Sao Paulo). 2020 Apr 06;75:e1507. (PMID: 32294669) Eur Arch Otorhinolaryngol. 2020 Oct 15;:. (PMID: 33057952) Rev Bras Epidemiol. 2015 Oct-Dec;18(4):894-905. (PMID: 26982303) Am J Surg Pathol. 2011 Sep;35(9):1343-50. (PMID: 21836494) Oncology. 2018;95(4):202-210. (PMID: 29975952) Oral Oncol. 2006 Jul;42(6):586-92. (PMID: 16469526) JAMA Otolaryngol Head Neck Surg. 2015 Jul;141(7):628-35. (PMID: 26042925) Br Dent J. 2018 Nov 9;225(9):815-819. (PMID: 30412550) Medicine (Baltimore). 2016 Jan;95(3):e2314. (PMID: 26817864) |
| سلسلة جزيئية: | figshare 10.6084/m9.figshare.13641449.v1 |
| تواريخ الأحداث: | Date Created: 20210217 Date Completed: 20210730 Latest Revision: 20210730 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC7888595 |
| DOI: | 10.1371/journal.pone.0246475 |
| PMID: | 33596233 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!